Therapy with omalizumab: evaluation of effectiveness and safety in 27 patients with severe uncontrolled asthma

被引：0
|
作者：
Caiaffa, M. [1 ]
De Serio, A. [1 ]
Bellotti, A. [1 ]
Rucco, A. [2 ]
Lotti, A. [2 ]
Loconte, F. [2 ]
Kourtis, G. [2 ]
Macchia, L. [2 ]
机构：
[1] Univ Foggia, Dept Allergol & Clin Immunol, Foggia, Italy
[2] Univ Bari, Dept Allergol & Clin Immunol, Bari, Italy
来源：
ALLERGY | 2009年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
786
引用
收藏
页码：307 / 307
页数：1
相关论文
共 50 条
  • [21] Severe uncontrolled asthma in patients over 75 years old: Treatment with omalizumab
    Romand, P.
    Kelkel, E.
    Saint-Raymond, C.
    Glas, N.
    Caillaud, D.
    Devouassoux, G.
    REVUE DES MALADIES RESPIRATOIRES, 2016, 33 (05) : 397 - 400
  • [22] Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting
    Suzuki, Cibele
    da Silva, Nilceia Lopes
    Kumar, Praveen
    Pathak, Purnima
    Ong, Siew Hwa
    JOURNAL OF MEDICAL ECONOMICS, 2017, 20 (08) : 832 - 839
  • [23] Adding Omalizumab to the Therapy of Adolescents With Persistent Uncontrolled Moderate-Severe Allergic Asthma
    Massanari, M.
    Milgrom, H.
    Pollard, S.
    Maykut, R. J.
    Kianifard, Farid
    Fowler-Taylor, A.
    Geba, G. P.
    Zeldin, R. K.
    CLINICAL PEDIATRICS, 2009, 48 (08) : 859 - 865
  • [24] Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients
    Ozseker, Z. F.
    Bulut, I
    Erdenen, F.
    Erdogdu, D.
    Asli, G.
    Ersoy, R.
    Kutlu, A.
    Ozturk, S.
    ALLERGY, 2013, 68 : 363 - 364
  • [25] Long-term safety, efficacy, pharmacokinetics and pharmacodynamics of omalizumab in children with severe uncontrolled asthma
    Odajima, Hiroshi
    Ebisawa, Motohiro
    Nagakura, Toshikazu
    Fujisawa, Takao
    Akasawa, Akira
    Ito, Komei
    Doi, Satoru
    Yamaguchi, Koichi
    Katsunuma, Toshio
    Kurihara, Kazuyuki
    Teramoto, Takahide
    Sugai, Kazuko
    Nambu, Mitsuhiko
    Hoshioka, Akira
    Yoshihara, Shigemi
    Sato, Norio
    Seko, Noriko
    Nishima, Sankei
    ALLERGOLOGY INTERNATIONAL, 2017, 66 (01) : 106 - 115
  • [26] Effectiveness of omalizumab therapy in patients with highly severe allergic asthma treated in Department of Pulmonology in Krakow
    Gawlewicz-Mroczka, Agnieszka
    Zastrzezynska, Weronika
    Przybyszowski, Marek
    Cmiel, Adam
    Sladek, Krzysztof
    ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY, 2016, 3 (04) : 127 - 133
  • [27] An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma
    Sullivan, S. D.
    Turk, F.
    ALLERGY, 2008, 63 (06) : 670 - 684
  • [28] Efficacy of mepolizumab and omalizumab combination therapy in uncontrolled asthma
    Sezgin, Mehmet Emin
    Colak, Mustafa
    Caglayan, Ozge
    Senel, Merve Yumrukuz
    Sezgin, Esma Nur Aktepe
    Coban, Hikmet
    Sarioglu, Nurhan
    Gemicioglu, Bilun
    Erel, Fuat
    JOURNAL OF ASTHMA, 2024, 61 (02) : 173 - 175
  • [29] SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA
    Kozlova, Ekaterina
    Akulova, Alena
    Stepanova, Olga
    Shapovalov, Konstantin
    Lukyanov, Sergey
    Rosenberg, Oleg
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [30] Effectiveness and Safety Studies of Omalizumab in Children and Adolescents With Moderate-To-Severe Asthma
    Cheng, Lu
    Yang, Tianrui
    Ma, Xiang
    Han, Yuling
    Wang, Yongtai
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (02) : 370 - 382
12345